{"protocolSection": {"identificationModule": {"nctId": "NCT04111185", "orgStudyIdInfo": {"id": "Pro00102851"}, "organization": {"fullName": "Duke University", "class": "OTHER"}, "briefTitle": "Daxor - Blood Volume Analysis", "officialTitle": "Blood Volume Analysis - Guided Heart Failure Management"}, "statusModule": {"statusVerifiedDate": "2023-06", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2020-07-16", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2021-07-15", "type": "ACTUAL"}, "completionDateStruct": {"date": "2021-09-23", "type": "ACTUAL"}, "studyFirstSubmitDate": "2019-09-23", "studyFirstSubmitQcDate": "2019-09-30", "studyFirstPostDateStruct": {"date": "2019-10-01", "type": "ACTUAL"}, "resultsFirstSubmitDate": "2022-07-08", "resultsFirstSubmitQcDate": "2022-09-02", "resultsFirstPostDateStruct": {"date": "2022-09-29", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2023-06-08", "lastUpdatePostDateStruct": {"date": "2023-06-28", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Duke University", "class": "OTHER"}, "collaborators": [{"name": "Daxor Corporation", "class": "INDUSTRY"}]}, "oversightModule": {"oversightHasDmc": false, "isFdaRegulatedDrug": false, "isFdaRegulatedDevice": true, "isUsExport": false}, "descriptionModule": {"briefSummary": "The purpose of this study is to better understand blood volume status and whether knowledge of it can change and improve heart failure care.", "detailedDescription": "The purpose of this study is to better understand measurements of various parameters of congestion, the most significant of which is blood volume analysis. Blood volume analysis (BVA) measures how much blood is in the investigator's arteries and veins and is performed by using an IV and injecting a small amount of a radioactive material (I 131-labeled albumin). The study also involves blood tests, urine tests, blood pressure monitoring, an ultrasound, and measurement of lung fluid volume (by way of a vest). There will also be a 30-day follow-up phone call to assess symptoms and discuss any changes in medication."}, "conditionsModule": {"conditions": ["Heart Failure", "Congestive Heart Failure"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "DOUBLE", "whoMasked": ["PARTICIPANT", "CARE_PROVIDER"]}}, "enrollmentInfo": {"count": 31, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Receive Blood Volume Analysis Guided Treatment", "type": "EXPERIMENTAL", "description": "The health care team will be provided with BVA results and may use the information to make decisions regarding the participant's treatment.", "interventionNames": ["Device: Receive Blood Volume Analysis Guided Treatment"]}, {"label": "Receive Standard of Care Treatment", "type": "NO_INTERVENTION", "description": "The health care team will not be provided with the BVA results. The participant will receive the same treatment they would have received if they weren't in the study."}], "interventions": [{"type": "DEVICE", "name": "Receive Blood Volume Analysis Guided Treatment", "description": "The health care team will be given the results of the blood volume analysis along with guidance on how to provide treatment based on the analysis", "armGroupLabels": ["Receive Blood Volume Analysis Guided Treatment"], "otherNames": ["Daxor BVA-100"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Change in Whole Blood Volume", "timeFrame": "Baseline, and upon discharge (up to day 18)"}], "secondaryOutcomes": [{"measure": "Change in Congestion Metrics as Measured With a Clinical Congestion Score (Pulmonary Edema, Jugular Venous Pressure, Lower Extremity Edema and PND)", "description": "Comparison of baseline to follow up times", "timeFrame": "Baseline, day 1, day 2, day 3 and discharge (up to day 18)"}, {"measure": "Change in Mean NTpro-BNP Concentration (in pg/mL)", "timeFrame": "Baseline, day 1, day 2, day 3 and discharge (up to day 18); reported as change from baseline to discharge"}, {"measure": "Change in Weight (in kg)", "timeFrame": "Baseline, day 1, day 2, day 3 and discharge (up to day 18); reported as change from baseline to discharge"}, {"measure": "Change in Renal Function as Measured by Creatinine (mg/dL)", "timeFrame": "Baseline, day 1, day 2, day 3 and discharge (up to day 18); reported as change from baseline to discharge"}, {"measure": "Change in Renal Function as Measured by Blood Urea Nitrogen (mg/dL)", "description": "Comparison of baseline to follow up times", "timeFrame": "Baseline, day 1, day 2, day 3 and discharge (up to day 18)"}, {"measure": "Change in Renal Function as Measured by an Estimated Glomerular Filtration Rate (mL/Min/ 1.73m2)", "description": "Comparison of baseline to follow up times", "timeFrame": "Baseline, day 1, day 2, day 3 and discharge (up to day 18)"}, {"measure": "Change in Pulmonary Congestion as Measured Using Non-invasive Diagnostic Technology Such as the ReDS Vest (Radiofrequency) or Bio-impedance Based Technologies (Unitless Values)", "description": "Comparison of baseline to follow up times", "timeFrame": "Baseline, day 1, day 2, day 3 and discharge (up to day 18)"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n- Admission for acute decompensated heart failure to the cardiology service at Duke Hospital, Durham, North Carolina\n\nExclusion Criteria:\n\n* Age \\< 18 years\n* Ongoing pregnancy\n* Recent acute MI or hemodynamic instability: Acute MI (STEMI or Type I NSTEMI) within 7 days\n* Post heart transplantation or ongoing mechanical circulatory support\n* Progressive cardiogenic shock\n* Patients with Ventricular Assist Devices\n* End stage renal disease", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "G. Michael Felker, MD", "affiliation": "Duke University", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Duke University", "city": "Durham", "state": "North Carolina", "zip": "27710", "country": "United States", "geoPoint": {"lat": 35.99403, "lon": -78.89862}}]}, "ipdSharingStatementModule": {"ipdSharing": "NO"}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Receive Blood Volume Analysis Guided Treatment", "description": "The health care team will be provided with BVA (blood volume analysis) results and may use the information to make decisions regarding the participant's treatment.\n\nReceive Blood Volume Analysis Guided Treatment: The health care team will be given the results of the blood volume analysis along with guidance on how to provide treatment based on the analysis"}, {"id": "FG001", "title": "Receive Standard of Care Treatment", "description": "The health care team will not be provided with the BVA results. The participant will receive the same treatment they would have received if they weren't in the study."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "17"}, {"groupId": "FG001", "numSubjects": "14"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "17"}, {"groupId": "FG001", "numSubjects": "14"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Receive Blood Volume Analysis Guided Treatment", "description": "The health care team will be provided with BVA results and may use the information to make decisions regarding the participant's treatment.\n\nReceive Blood Volume Analysis Guided Treatment: The health care team will be given the results of the blood volume analysis along with guidance on how to provide treatment based on the analysis"}, {"id": "BG001", "title": "Receive Standard of Care Treatment", "description": "The health care team will not be provided with the BVA results. The participant will receive the same treatment they would have received if they weren't in the study."}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "17"}, {"groupId": "BG001", "value": "14"}, {"groupId": "BG002", "value": "31"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "62", "spread": "32"}, {"groupId": "BG001", "value": "60", "spread": "30"}, {"groupId": "BG002", "value": "61", "spread": "31"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "5"}, {"groupId": "BG001", "value": "3"}, {"groupId": "BG002", "value": "8"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "12"}, {"groupId": "BG001", "value": "11"}, {"groupId": "BG002", "value": "23"}]}]}]}, {"title": "Ethnicity (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Not Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "17"}, {"groupId": "BG001", "value": "14"}, {"groupId": "BG002", "value": "31"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "9"}, {"groupId": "BG001", "value": "8"}, {"groupId": "BG002", "value": "17"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "8"}, {"groupId": "BG001", "value": "6"}, {"groupId": "BG002", "value": "14"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}]}]}, {"title": "Region of Enrollment", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "17"}, {"groupId": "BG001", "value": "14"}, {"groupId": "BG002", "value": "31"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Change in Whole Blood Volume", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mL", "timeFrame": "Baseline, and upon discharge (up to day 18)", "groups": [{"id": "OG000", "title": "Receive Blood Volume Analysis Guided Treatment", "description": "The health care team will be provided with BVA results and may use the information to make decisions regarding the participant's treatment.\n\nReceive Blood Volume Analysis Guided Treatment: The health care team will be given the results of the blood volume analysis along with guidance on how to provide treatment based on the analysis"}, {"id": "OG001", "title": "Receive Standard of Care Treatment", "description": "The health care team will not be provided with the BVA results. The participant will receive the same treatment they would have received if they weren't in the study."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "17"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-1253", "spread": "2157"}, {"groupId": "OG001", "value": "-784", "spread": "981"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "OTHER", "pValue": ">0.05", "statisticalMethod": "t-test, 2 sided"}]}, {"type": "SECONDARY", "title": "Change in Congestion Metrics as Measured With a Clinical Congestion Score (Pulmonary Edema, Jugular Venous Pressure, Lower Extremity Edema and PND)", "description": "Comparison of baseline to follow up times", "populationDescription": "Data not collected.", "reportingStatus": "POSTED", "timeFrame": "Baseline, day 1, day 2, day 3 and discharge (up to day 18)", "groups": [{"id": "OG000", "title": "Receive Blood Volume Analysis Guided Treatment", "description": "The health care team will be provided with BVA results and may use the information to make decisions regarding the participant's treatment.\n\nReceive Blood Volume Analysis Guided Treatment: The health care team will be given the results of the blood volume analysis along with guidance on how to provide treatment based on the analysis"}, {"id": "OG001", "title": "Receive Standard of Care Treatment", "description": "The health care team will not be provided with the BVA results. The participant will receive the same treatment they would have received if they weren't in the study."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"type": "SECONDARY", "title": "Change in Mean NTpro-BNP Concentration (in pg/mL)", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "pg/mL", "timeFrame": "Baseline, day 1, day 2, day 3 and discharge (up to day 18); reported as change from baseline to discharge", "groups": [{"id": "OG000", "title": "Receive Blood Volume Analysis Guided Treatment", "description": "The health care team will be provided with BVA results and may use the information to make decisions regarding the participant's treatment.\n\nReceive Blood Volume Analysis Guided Treatment: The health care team will be given the results of the blood volume analysis along with guidance on how to provide treatment based on the analysis"}, {"id": "OG001", "title": "Receive Standard of Care Treatment", "description": "The health care team will not be provided with the BVA results. The participant will receive the same treatment they would have received if they weren't in the study."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "17"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-853", "spread": "3154"}, {"groupId": "OG001", "value": "-4849", "spread": "6770"}]}]}]}, {"type": "SECONDARY", "title": "Change in Weight (in kg)", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "kg", "timeFrame": "Baseline, day 1, day 2, day 3 and discharge (up to day 18); reported as change from baseline to discharge", "groups": [{"id": "OG000", "title": "Receive Blood Volume Analysis Guided Treatment", "description": "The health care team will be provided with BVA results and may use the information to make decisions regarding the participant's treatment.\n\nReceive Blood Volume Analysis Guided Treatment: The health care team will be given the results of the blood volume analysis along with guidance on how to provide treatment based on the analysis"}, {"id": "OG001", "title": "Receive Standard of Care Treatment", "description": "The health care team will not be provided with the BVA results. The participant will receive the same treatment they would have received if they weren't in the study."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "17"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-6.4", "spread": "5.4"}, {"groupId": "OG001", "value": "-10.1", "spread": "10.6"}]}]}]}, {"type": "SECONDARY", "title": "Change in Renal Function as Measured by Creatinine (mg/dL)", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mg/dL", "timeFrame": "Baseline, day 1, day 2, day 3 and discharge (up to day 18); reported as change from baseline to discharge", "groups": [{"id": "OG000", "title": "Receive Blood Volume Analysis Guided Treatment", "description": "The health care team will be provided with BVA results and may use the information to make decisions regarding the participant's treatment.\n\nReceive Blood Volume Analysis Guided Treatment: The health care team will be given the results of the blood volume analysis along with guidance on how to provide treatment based on the analysis"}, {"id": "OG001", "title": "Receive Standard of Care Treatment", "description": "The health care team will not be provided with the BVA results. The participant will receive the same treatment they would have received if they weren't in the study."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "17"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.1", "spread": "0.3"}, {"groupId": "OG001", "value": "0.2", "spread": "0.3"}]}]}]}, {"type": "SECONDARY", "title": "Change in Renal Function as Measured by Blood Urea Nitrogen (mg/dL)", "description": "Comparison of baseline to follow up times", "populationDescription": "Data not collected.", "reportingStatus": "POSTED", "timeFrame": "Baseline, day 1, day 2, day 3 and discharge (up to day 18)", "groups": [{"id": "OG000", "title": "Receive Blood Volume Analysis Guided Treatment", "description": "The health care team will be provided with BVA results and may use the information to make decisions regarding the participant's treatment.\n\nReceive Blood Volume Analysis Guided Treatment: The health care team will be given the results of the blood volume analysis along with guidance on how to provide treatment based on the analysis"}, {"id": "OG001", "title": "Receive Standard of Care Treatment", "description": "The health care team will not be provided with the BVA results. The participant will receive the same treatment they would have received if they weren't in the study."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"type": "SECONDARY", "title": "Change in Renal Function as Measured by an Estimated Glomerular Filtration Rate (mL/Min/ 1.73m2)", "description": "Comparison of baseline to follow up times", "populationDescription": "Data not collected.", "reportingStatus": "POSTED", "timeFrame": "Baseline, day 1, day 2, day 3 and discharge (up to day 18)", "groups": [{"id": "OG000", "title": "Receive Blood Volume Analysis Guided Treatment", "description": "The health care team will be provided with BVA results and may use the information to make decisions regarding the participant's treatment.\n\nReceive Blood Volume Analysis Guided Treatment: The health care team will be given the results of the blood volume analysis along with guidance on how to provide treatment based on the analysis"}, {"id": "OG001", "title": "Receive Standard of Care Treatment", "description": "The health care team will not be provided with the BVA results. The participant will receive the same treatment they would have received if they weren't in the study."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"type": "SECONDARY", "title": "Change in Pulmonary Congestion as Measured Using Non-invasive Diagnostic Technology Such as the ReDS Vest (Radiofrequency) or Bio-impedance Based Technologies (Unitless Values)", "description": "Comparison of baseline to follow up times", "populationDescription": "Data not collected.", "reportingStatus": "POSTED", "timeFrame": "Baseline, day 1, day 2, day 3 and discharge (up to day 18)", "groups": [{"id": "OG000", "title": "Receive Blood Volume Analysis Guided Treatment", "description": "The health care team will be provided with BVA results and may use the information to make decisions regarding the participant's treatment.\n\nReceive Blood Volume Analysis Guided Treatment: The health care team will be given the results of the blood volume analysis along with guidance on how to provide treatment based on the analysis"}, {"id": "OG001", "title": "Receive Standard of Care Treatment", "description": "The health care team will not be provided with the BVA results. The participant will receive the same treatment they would have received if they weren't in the study."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "Up to 18 days", "eventGroups": [{"id": "EG000", "title": "Receive Blood Volume Analysis Guided Treatment", "description": "The health care team will be provided with BVA results and may use the information to make decisions regarding the participant's treatment.\n\nReceive Blood Volume Analysis Guided Treatment: The health care team will be given the results of the blood volume analysis along with guidance on how to provide treatment based on the analysis", "deathsNumAffected": 0, "deathsNumAtRisk": 17, "seriousNumAffected": 0, "seriousNumAtRisk": 17, "otherNumAffected": 0, "otherNumAtRisk": 17}, {"id": "EG001", "title": "Receive Standard of Care Treatment", "description": "The health care team will not be provided with the BVA results. The participant will receive the same treatment they would have received if they weren't in the study.", "deathsNumAffected": 0, "deathsNumAtRisk": 14, "seriousNumAffected": 0, "seriousNumAtRisk": 14, "otherNumAffected": 0, "otherNumAtRisk": 14}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": true}, "pointOfContact": {"title": "Marat Fudim, MD, MHS", "organization": "Duke University", "email": "marat.fudim@duke.edu", "phone": "919-684-1284"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot_SAP", "hasProtocol": true, "hasSap": true, "hasIcf": false, "label": "Study Protocol and Statistical Analysis Plan", "date": "2020-02-24", "uploadDate": "2022-07-08T13:45", "filename": "Prot_SAP_000.pdf", "size": 244150}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24", "submissionTracking": {"firstMcpInfo": {"postDateStruct": {"date": "2022-08-02", "type": "ACTUAL"}}}}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}}, "hasResults": true}